Does Pulmonary Aspergillosis Complicate Coronavirus Disease 2019?

Beer, Karlyn D.; Jackson, Brendan R.; Chiller, Tom; Verweij, Paul E.; Van de Veerdonk, Frank L.; Wauters, Joost

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Does Pulmonary Aspergillosis Complicate Coronavirus Disease 2019?

September 15 2020
By Beer, Karlyn D. ; Jackson, Brendan R. ; Chiller, Tom ; ...
Source: Crit Care Explor. 2020; 2(9)

[PDF-716.08 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Crit Care Explor
Personal Author:

Beer, Karlyn D. ; Jackson, Brendan R. ; Chiller, Tom ; Verweij, Paul E. ; Van de Veerdonk, Frank L. ; ... More +

Beer, Karlyn D. ; Jackson, Brendan R. ; Chiller, Tom ; Verweij, Paul E. ; Van de Veerdonk, Frank L. ; Wauters, Joost Less -
Description:

Objectives:

Aspergillus coinfection in coronavirus disease 2019 patients has rarely been described but may be occurring among coronavirus disease 2019 patients admitted to ICUs. Previous reports of viral coinfections with Aspergillus, including influenza-associated pulmonary aspergillosis, suggest that coronavirus disease 2019–associated aspergillosis is plausible. This report aims to summarize what is known about coronavirus disease 2019 complicated by Aspergillus, introduces coronavirus disease 2019–associated pulmonary aspergillosis as a possible clinical entity, and describes reasons clinical suspicion of Aspergillus is warranted in the critical care setting.

Data Sources:

We summarize the available evidence suggesting the existence of Aspergillus coinfection among severe coronavirus disease 2019 patients. This includes published coronavirus disease 2019 patient case series, a case description, and a review of potential biologic mechanisms.

Study Selection:

Reports of coronavirus disease 2019 patient attributes were selected if they included clinical, microbiologic, or radiologic signs of invasive fungal infection.

Data Extraction:

Data included in summary tables were identified through a literature search for coronavirus disease 2019–associated pulmonary aspergillosis.

Data Synthesis:

We present descriptive data extracted from coronavirus disease 2019–associated pulmonary aspergillosis case series current at the time of article submission.

Discussion:

Pulmonary aspergillosis is known to occur among influenza patients requiring intensive care and is associated with increased mortality. If Aspergillus coinfections are occurring among coronavirus disease 2019 patients, early clinical suspicion and testing are needed to understand the epidemiology of these infections and prevent associated mortality. As the coronavirus disease 2019 pandemic unfolds, reports on the existence of this coinfection are needed, and opportunities to contribute cases of Aspergillus coinfection among coronavirus disease 2019 patients to an ongoing registry are described.
Subjects:

[+]

Aspergillus Fumigatus COVID-19 Pulmonary Aspergillosis
Source:

Crit Care Explor. 2020; 2(9)
Pubmed ID:

32984834
Pubmed Central ID:

PMC7498132
Document Type:

Journal Article
Volume:

2
Issue:

9
Collection(s):

CDC Public Access
Main Document Checksum:

[+]

urn:sha256:c441dbd5920f3df9292da71c0c1eaeef78fd08e0501666b52d3d96705d3c73dc
Download URL:

https://stacks.cdc.gov/view/cdc/94560/cdc_94560_DS1.pdf
File Type:

cc9-2-e0211.nxml

xml

More +